InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Bruno Julianne. Insider active across 2 companies, notably CRISPR Therapeutics AG. In total, 5 filings have been recorded. History available since 9 February 2026. The latest transaction was disclosed on 9 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Bruno Julianne is a declarant linked to CRISPR Therapeutics AG, where he is Chief Operating Officer, and to Galecto, Inc., where he is a Director. His 5 filings run from 2024-06-24 to 2026-02-12, and the sampled recent filings indicate a transaction nature of option exercise, with buy and sell amounts of 0.